XML 32 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Sep. 30, 2017
STOCKHOLDERS' EQUITY (Tables) [Line Items]  
Share-based expense [Table Text Block]
Share-based expense consisted of the following:

 

 

Three months ended

September 30,

 

Nine months ended

September 30,

 

 

2017

 

2016

 

2017

 

2016

Employee Awards

$

839,322

$

740,844

$

2,969,811

$

1,574,906

Consulting Awards

 

 

103,869

 

25,440

 

151,385

Feinsod Agreement

 

 

27,504

 

 

192,800

DB Option Agreement

 

 

 

 

55,100

 

$

839,322

$

872,217

$

2,995,251

$

1,974,191

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
The following summarizes Employee Awards activity:

 

 

Number of Shares

 

Weighted-average Exercise Price per Share

 

Weighted-average Remaining Contractual Term

(in years)

 

Aggregate Intrinsic Value

Outstanding at December 31, 2016

 

8,818,400

$

1.04

 

 

 

 

Granted

 

1,116,400

 

1.78

 

 

 

 

Exercised

 

(367,240)

 

1.09

 

 

 

 

Forfeited

 

(554,050)

 

0.75

 

 

 

 

Outstanding at September 30, 2017

 

9,013,510

 

1.14

 

2.2

$

6,211,944

 

 

 

 

 

 

 

 

 

Exercisable at September 30, 2017

 

7,984,960

$

1.00

 

1.9

$

5,726,885

 

 

Number of Shares

 

Weighted-average Exercise Price per Share

 

Weighted-average Remaining Contractual Term

(in years)

 

Aggregate Intrinsic Value

Outstanding at December 31, 2016

 

9,025,843

$

0.63

 

 

 

 

Exercised

 

(3,377,587)

$

0.59

 

 

 

 

Forfeited

 

(28,126)

 

1.20

 

 

 

 

Outstanding and exercisable at September 30, 2017

 

5,620,130

$

0.69

 

2.1

$

4,573,359

Employee Awards  
STOCKHOLDERS' EQUITY (Tables) [Line Items]  
Schedule of Assumptions Used [Table Text Block]
The following summarizes the Black-Scholes assumptions used for Employee Awards granted:

 

Three months ended

 

September 30, 2017

June 30,

2017

March 31,

2017

Exercise price

$1.34 – 2.07

$1.92

$2.41 – 3.00

Stock price on date of grant

$1.34 – 2.07

$1.92

$2.41 – 3.00

Volatility

140 – 142%

145%

148 – 153%

Risk-free interest rate

1.4 – 1.9%

1.8%

1.7 – 1.9%

Expected life (years)

3.0 – 5.0

5.0

4.0 – 5.0

Dividend yield